Pathophysiology, prevention, and treatment of medication overuse headache

Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt

Standard

Pathophysiology, prevention, and treatment of medication overuse headache. / Diener, Hans Christoph; Dodick, D.; Evers, Stefan; Holle, D.; Jensen, Rigmor Hoejland; Lipton, Richard B.; Porreca, F.; Silberstein, Stephen; Schwedt, Todd.

I: The Lancet Neurology, Bind 18, Nr. 9, 2019, s. 891-902.

Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt

Harvard

Diener, HC, Dodick, D, Evers, S, Holle, D, Jensen, RH, Lipton, RB, Porreca, F, Silberstein, S & Schwedt, T 2019, 'Pathophysiology, prevention, and treatment of medication overuse headache', The Lancet Neurology, bind 18, nr. 9, s. 891-902. https://doi.org/10.1016/S1474-4422(19)30146-2

APA

Diener, H. C., Dodick, D., Evers, S., Holle, D., Jensen, R. H., Lipton, R. B., Porreca, F., Silberstein, S., & Schwedt, T. (2019). Pathophysiology, prevention, and treatment of medication overuse headache. The Lancet Neurology, 18(9), 891-902. https://doi.org/10.1016/S1474-4422(19)30146-2

Vancouver

Diener HC, Dodick D, Evers S, Holle D, Jensen RH, Lipton RB o.a. Pathophysiology, prevention, and treatment of medication overuse headache. The Lancet Neurology. 2019;18(9):891-902. https://doi.org/10.1016/S1474-4422(19)30146-2

Author

Diener, Hans Christoph ; Dodick, D. ; Evers, Stefan ; Holle, D. ; Jensen, Rigmor Hoejland ; Lipton, Richard B. ; Porreca, F. ; Silberstein, Stephen ; Schwedt, Todd. / Pathophysiology, prevention, and treatment of medication overuse headache. I: The Lancet Neurology. 2019 ; Bind 18, Nr. 9. s. 891-902.

Bibtex

@article{f164eb703054402cb87194e05311ff43,

title = "Pathophysiology, prevention, and treatment of medication overuse headache",

abstract = "Regular or frequent use of analgesics and acute antimigraine drugs can increase the frequency of headache, and induce the transition from episodic to chronic headache or medication overuse headache. The 1-year prevalence of this condition in the general population is between 1% and 2%. Medication overuse headache is more common in women and in people with comorbid depression, anxiety, and other chronic pain conditions. Treatment of medication overuse headache has three components. First, patients need education and counselling to reduce the intake of medication for acute headache attacks. Second, some patients benefit from drug withdrawal (discontinuation of the overused medication). Finally, preventive drug therapy and non-medical prevention might be necessary in patients at onset of treatment or in patients who do not respond to the first two steps. The optimal therapeutic approach requires validation in controlled trials.",

author = "Diener, {Hans Christoph} and D. Dodick and Stefan Evers and D. Holle and Jensen, {Rigmor Hoejland} and Lipton, {Richard B.} and F. Porreca and Stephen Silberstein and Todd Schwedt",

year = "2019",

doi = "10.1016/S1474-4422(19)30146-2",

language = "English",

volume = "18",

pages = "891--902",

journal = "The Lancet Neurology",

issn = "1474-4422",

publisher = "TheLancet Publishing Group",

number = "9",

}

RIS

TY - JOUR

T1 - Pathophysiology, prevention, and treatment of medication overuse headache

AU - Diener, Hans Christoph

AU - Dodick, D.

AU - Evers, Stefan

AU - Holle, D.

AU - Jensen, Rigmor Hoejland

AU - Lipton, Richard B.

AU - Porreca, F.

AU - Silberstein, Stephen

AU - Schwedt, Todd

PY - 2019

Y1 - 2019

N2 - Regular or frequent use of analgesics and acute antimigraine drugs can increase the frequency of headache, and induce the transition from episodic to chronic headache or medication overuse headache. The 1-year prevalence of this condition in the general population is between 1% and 2%. Medication overuse headache is more common in women and in people with comorbid depression, anxiety, and other chronic pain conditions. Treatment of medication overuse headache has three components. First, patients need education and counselling to reduce the intake of medication for acute headache attacks. Second, some patients benefit from drug withdrawal (discontinuation of the overused medication). Finally, preventive drug therapy and non-medical prevention might be necessary in patients at onset of treatment or in patients who do not respond to the first two steps. The optimal therapeutic approach requires validation in controlled trials.

AB - Regular or frequent use of analgesics and acute antimigraine drugs can increase the frequency of headache, and induce the transition from episodic to chronic headache or medication overuse headache. The 1-year prevalence of this condition in the general population is between 1% and 2%. Medication overuse headache is more common in women and in people with comorbid depression, anxiety, and other chronic pain conditions. Treatment of medication overuse headache has three components. First, patients need education and counselling to reduce the intake of medication for acute headache attacks. Second, some patients benefit from drug withdrawal (discontinuation of the overused medication). Finally, preventive drug therapy and non-medical prevention might be necessary in patients at onset of treatment or in patients who do not respond to the first two steps. The optimal therapeutic approach requires validation in controlled trials.

U2 - 10.1016/S1474-4422(19)30146-2

DO - 10.1016/S1474-4422(19)30146-2

M3 - Review

C2 - 31174999

AN - SCOPUS:85071349577

VL - 18

SP - 891

EP - 902

JO - The Lancet Neurology

JF - The Lancet Neurology

SN - 1474-4422

IS - 9

ER -

ID: 240624287